NewPath Partners is a strategic advisory and investment firm that specializes in supporting innovative companies in the healthcare sector. The firm leverages its deep industry expertise to help businesses grow, offering guidance on market expansion, strategic partnerships, and capital allocation.

NewPath Partners

Newpath is a private venture capital investment fund focused on disruptive treatments and technologies in the life science space. We search for innovative approaches across diverse fields including but not limited to: pharmaceuticals, regenerative and personalized medicine, basic sciences, devices, drug discovery, cellular and gene therapies, robotics, AR/VR and AI. With each investment, Newpath seeks to optimize performance by aligning the interests of academic founders, management teams, and investor groups.

Metric
Company Name	NewPath Partners
Symbol
MSH ID	PARTNERS:NEWPATH
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare Advisory and Investment
Country	US
Stage
Employee Count	5
Website	newpath.partners
LinkedIn	newpath-partners
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.36
28-Day Growth Score	16.39
90-Day Growth Score	14.09
365-Day Growth Score	13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PARTNERS:NEWPATH

NewPath Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue